Is It Time for Endocrinologists to Join the Vascular Care Team?
As the link between diabetes and PAD becomes more evident, clinicians can best serve patients with these comorbidities by working collaboratively to prevent serious complications.
Peripheral Artery Disease
FDA: Potential Increased Mortality With Paclitaxel-Coated Balloons, Stents for PAD
The FDA’s communication follows a recent meta-analysis published in the Journal of the American Heart Association.
Peripheral Artery Disease: Incidence and Outcomes of Myocardial Infarction
Myocardial infarction was associated with an increased risk of cardiovascular death and
acute limb ischemia in patients with peripheral artery disease.
ACC, AHA Publish Appropriate Use Criteria Guidelines for Peripheral Artery Intervention
In publishing updated appropriate use criteria, the organizations hope to provide guidance to clinicians who may refer patients for revascularization therapy.
Calcium Channel Blockers May Reduce Peripheral Arterial Disease Risk in Hypertensive Patients
Meta-analysis suggests that calcium channel blockers can be effective in preventing peripheral arterial disease in patients with hypertension.
FDA Approves Eluvia Drug-Eluting Stent for Peripheral Artery Disease
The Eluvia stent is designed to release paclitaxel for a 1-year time frame to prevent tissue regrowth that might otherwise block the stented artery.
Anti-Nicotine Monoclonal Antibody Gets Orphan Drug Status for Buerger’s Disease
Buerger’s disease is a nonatherosclerotic, segmental inflammatory disorder that affects small and medium vessels of the upper and lower extremities and is strongly associated with tobacco exposure.
USPSTF: Evidence Lacking for ABI for PAD Screening in Asymptomatic Adults
No direct evidence and limited indirect evidence for benefits of peripheral artery disease screening in asymptomatic population.
At-Home Exercise vs Usual Care for Improving Walking Performance in PAD
An at-home exercise intervention using a wearable activity monitor and telephone coaching did not improve walking performance in patients with peripheral artery disease compared with usual care.
Afib Risk Not Affected by Borderline ABI in Peripheral Artery Disease
Peripheral artery disease with a borderline ankle-branchial index appears not to increase the risk for atrial fibrillation.
Next post in Atrial Fibrillation
